Sustained reductions in inflammatory markers seen with novel antibody drug

1 month ago 5
The interleukin-6 (IL-6) antibody pacibekitug produced sustained reductions successful inflammatory biomarkers successful patients with chronic kidney illness astatine precocious inflammatory risk, according to results from the Phase II TRANQUILITY proceedings presented successful a Hot Line league astatine ESC Congress 2026.
Read Entire Article